Sentence examples for suboptimal effectiveness from inspiring English sources
Even in the face of suboptimal effectiveness, coitally dependent methods likely will always have a role in fertility management.
In fact, suboptimal effectiveness of seasonal influenza vaccines has recently led researchers and policy makers to advocate for better vaccines [ 9, 12].
Current observations suggest that parasitologic confirmation tests of inadequate sensitivity lead to suboptimal effectiveness of HAT active case-finding programs (4 ).
It is possible that both recent use of typical antipsychotics and antipsychotic switching/augmentation reflect suboptimal effectiveness and/or greater medication intolerability in this patient group, thus leading clinicians to alter antipsychotic treatment in an attempt to improve patients' outcomes.
Data from randomized, controlled trials of antipruritic agents used for treatment of itch are limited, and treatments currently used in clinical practice have variable and, in most cases, suboptimal effectiveness.
Given the suboptimal effectiveness of current efforts to implement DPP-like lifestyle programs, providing individuals at risk for diabetes with new tools to improve their motivation and adherence, such as their individual diabetes genotype scores, has the potential for substantial clinical impact.
Studies of treatments designed to remove fibrils or to prevent their formation may be ineffective or suboptimal in effectiveness because they do not reduce the relevant amyloid burden and/or fail to alter the arrangement of shorter multimers of amyloid beta around its P-protein and glycan core.
Suboptimal treatment effectiveness may lead to complications, diminished quality-of-life and general health status, and premature death.
From a clinical standpoint, the phenomenon gives rise to diverse snakebite syndromes and potentially suboptimal antivenom effectiveness.
25 Polypharmacy can also augment the risk for medication non-adherence, which in turn can lead to suboptimal therapeutic effectiveness and poor clinical consequences.
It is important to understand that this rebound caused by a suboptimal drug effectiveness can occur only in models with a nonconstant number of target cells.
